ATE160359T1 - Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen. - Google Patents

Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen.

Info

Publication number
ATE160359T1
ATE160359T1 AT93916141T AT93916141T ATE160359T1 AT E160359 T1 ATE160359 T1 AT E160359T1 AT 93916141 T AT93916141 T AT 93916141T AT 93916141 T AT93916141 T AT 93916141T AT E160359 T1 ATE160359 T1 AT E160359T1
Authority
AT
Austria
Prior art keywords
tlp
antibodies
complexes
pct
recognize
Prior art date
Application number
AT93916141T
Other languages
English (en)
Inventor
Giulio Tarro
Original Assignee
Ist Farmacoterapico It Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Farmacoterapico It Spa filed Critical Ist Farmacoterapico It Spa
Application granted granted Critical
Publication of ATE160359T1 publication Critical patent/ATE160359T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93916141T 1992-07-03 1993-07-01 Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen. ATE160359T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920506A IT1262954B (it) 1992-07-03 1992-07-03 Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.

Publications (1)

Publication Number Publication Date
ATE160359T1 true ATE160359T1 (de) 1997-12-15

Family

ID=11401092

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93916141T ATE160359T1 (de) 1992-07-03 1993-07-01 Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen.

Country Status (14)

Country Link
US (3) US5747643A (de)
EP (1) EP0649433B1 (de)
JP (1) JP2958118B2 (de)
KR (1) KR100237250B1 (de)
AT (1) ATE160359T1 (de)
AU (1) AU680198B2 (de)
BR (1) BR9306663A (de)
CA (1) CA2139518C (de)
DE (1) DE69315341T2 (de)
DK (1) DK0649433T3 (de)
ES (1) ES2111757T3 (de)
IT (1) IT1262954B (de)
RU (1) RU2141969C1 (de)
WO (1) WO1994001458A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1284870B1 (it) * 1996-07-10 1998-05-22 Ist Farmacoterapico It Spa Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi
IT1294967B1 (it) * 1996-10-09 1999-04-23 Ist Farmacoterapico It Spa Composizione immunogenica da tlp
IT1317853B1 (it) * 2000-02-25 2003-07-15 Unihart Corp Peptidi tlp e sequenze di dna che li codificano.
US20030157116A1 (en) * 2000-02-25 2003-08-21 Giulio Tarro Tlp peptides and dna sequences coding the same
CN1457255A (zh) 2001-02-14 2003-11-19 马蒂亚斯·拉特 参与细胞生物能代谢的生物化学化合物的组合物和其使用方法
RU2216742C2 (ru) * 2002-01-11 2003-11-20 Потин Владимир Всеволодович Способ количественного определения концентрации антител, специфичных к антигенам стероид-продуцирующих клеток человека, в биологических жидкостях человека, содержащих специфичные антитела
JP2008526194A (ja) 2004-12-30 2008-07-24 ヴィート ミケーレ ファツィオ 抗腫瘍免疫原性ペプチド及びそのワクチン
US20100255514A1 (en) 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
JP5769417B2 (ja) * 2007-08-16 2015-08-26 ザ ロイヤル インスティチューション フォー ザ アドバンスメント オブ ラーニング／マギル ユニバーシティ 腫瘍細胞由来微小胞
EP3167898A1 (de) 2015-11-11 2017-05-17 IEO - Istituto Europeo di Oncologia Srl Verfahren zur gewinnung von tumorpeptiden und verwendungen davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172686A (da) * 1985-04-22 1986-10-23 Hybritech Inc Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
ES8800604A1 (es) * 1985-04-22 1987-11-16 Hybritech Inc Un metodo para producir anticuerpos monoclonales
IT1206250B (it) * 1987-02-18 1989-04-14 Ist Farmacoterapico It Spa Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla-
RU2077725C1 (ru) * 1992-03-05 1997-04-20 Любовь Львовна Сольская Способ обнаружения раковоэмбрионального антигена при помощи специального антительного диагностикума

Also Published As

Publication number Publication date
JP2958118B2 (ja) 1999-10-06
AU680198B2 (en) 1997-07-24
US5747643A (en) 1998-05-05
US5877294A (en) 1999-03-02
BR9306663A (pt) 1998-12-08
EP0649433A1 (de) 1995-04-26
DK0649433T3 (da) 1998-07-27
JPH07508749A (ja) 1995-09-28
KR950702207A (ko) 1995-06-19
AU4582393A (en) 1994-01-31
EP0649433B1 (de) 1997-11-19
US5759792A (en) 1998-06-02
RU2141969C1 (ru) 1999-11-27
WO1994001458A1 (en) 1994-01-20
KR100237250B1 (ko) 2000-01-15
DE69315341T2 (de) 1999-03-18
ITRM920506A0 (it) 1992-07-03
IT1262954B (it) 1996-07-23
CA2139518C (en) 2003-09-23
RU94046337A (ru) 1996-10-27
DE69315341D1 (de) 1998-01-02
ES2111757T3 (es) 1998-03-16
ITRM920506A1 (it) 1994-01-03
CA2139518A1 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
ATE163195T1 (de) Lösliche liganden für cd40
ATE386808T1 (de) Arzneimittelzubereitungen für die behandlung von alpha-galactosidase a-mangel
DE60136099D1 (de) Zusammensetzungen zur behandlung und diagnose von eierstockkrebs
ES2124533T3 (es) Anticuerpos monoclonales inmunoestimulantes.
GR3026219T3 (en) Mouse monoclonal antibodies
ATE123652T1 (de) Antigene.
NO965621L (no) Nye hIL-4-mutantproteiner som antagonister eller partielle agonister for det humane interleukin 4
BG101024A (bg) Моноклонално антитяло срещу сd44v6
ATE160359T1 (de) Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen.
ATE120372T1 (de) Antikörper für die antilymphozyten- antikörpertherapie.
ATE120371T1 (de) Mittel zur neutralisierung der tumorzellen- assoziierten prokoagulant-aktivität.
ATE239035T1 (de) Durch hla-b44 moleküle präsentierte tumor- abstossungsantigene und ihre verwendungen
ATE133994T1 (de) An karzinoma assoziierte antigene und antikörper, die diese antigene erkennen
ATE475710T1 (de) Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs
ATE142229T1 (de) Neoglykoproteine, ihre herstellung und verwendung
DE68909515D1 (de) Durch antikoerper und liganden bewirkte zielrichtung von differentiationsinduktoren auf tumorzellen.
DE3855280D1 (de) Von mca 16-88 erkanntes antigen
EP0446797A3 (en) Synthetic peptides containing factor viia sequences and their use
ATE209041T1 (de) Durch hla-b44 moleküle präsentierte tumor- abstossungsantigene und ihre verwendung
ATE86261T1 (de) Tumorassoziiertes antigen.
EP0243058A3 (en) A novel tumor associated antigen
ATE105570T1 (de) Modifizierte menschliche anti-rh(d)-antikoerper.
NO952506L (no) Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker
ATE17190T1 (de) Mittel zur tumorlokalisierung und therapie mit markierten antikoerpern und antikoerperfragmenten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee